Used primarily in biological research, this compound is a key component in the development of PROTACs (Proteolysis Targeting Chimeras). These molecules are designed to target specific proteins for degradation within cells, offering a novel approach in drug discovery and therapeutic interventions. Its application is particularly significant in the study of cancer, neurodegenerative diseases, and other conditions where the selective removal of pathogenic proteins can be beneficial. The compound's structure allows it to effectively bind to both the target protein and the cellular degradation machinery, facilitating the elimination of disease-causing proteins. This makes it a valuable tool in the exploration of new treatments and the understanding of protein function and regulation in various diseases.